2014 - Canada Gairdner International Award
2006 - Szent-Györgyi Prize for Progress in Cancer Research, National Foundation for Cancer Research (NFCR)
1999 - Fellow of the American Association for the Advancement of Science (AAAS)
Member of the Association of American Physicians
His primary areas of investigation include Angiogenesis, Pathology, Vascular endothelial growth factor A, Vascular endothelial growth factor and Vascular permeability. His Angiogenesis study combines topics from a wide range of disciplines, such as Blood vessel, Cancer and Immunology, Fibrin. Harold F. Dvorak combines subjects such as Cellular immunity, Coagulation, Receptor, VEGF receptors and Pathological Angiogenesis with his study of Pathology.
His biological study spans a wide range of topics, including Endothelial stem cell and Endocrinology. Vascular endothelial growth factor is a subfield of Cancer research that Harold F. Dvorak studies. His Vascular permeability research is multidisciplinary, incorporating elements of Secretion, Blood proteins, Microcirculation, Extravasation and Antibody.
Harold F. Dvorak mainly focuses on Pathology, Immunology, Angiogenesis, Vascular endothelial growth factor and Cell biology. His Pathology study combines topics in areas such as Blood vessel, Endothelium, Wound healing and Fibrin. In his study, Growth factor is strongly linked to Vascular endothelial growth factor A, which falls under the umbrella field of Angiogenesis.
His work deals with themes such as Endothelial stem cell, Endocrinology and Cytokine, which intersect with Vascular endothelial growth factor. The concepts of his Cell biology study are interwoven with issues in Mast cell, Cell and Degranulation. Harold F. Dvorak has included themes like Cancer and In situ hybridization in his Cancer research study.
Harold F. Dvorak mainly investigates Angiogenesis, Pathology, Vascular endothelial growth factor A, Cancer research and Cell biology. His Angiogenesis research is multidisciplinary, incorporating perspectives in Endothelial stem cell, Vascular endothelial growth factor, Immunology and Vascular permeability. His Immunology research integrates issues from Vascular endothelial growth factor C and Skeletal muscle.
His Pathology study integrates concerns from other disciplines, such as Blood vessel, VEGF receptors, Pathological Angiogenesis and Arteriogenesis. His research investigates the connection between Vascular endothelial growth factor A and topics such as Transcription factor that intersect with issues in Calcineurin and Tube formation. His Cell biology research is multidisciplinary, incorporating elements of Cell, Cell type, Endothelium and Molecular biology.
Harold F. Dvorak focuses on Angiogenesis, Pathology, Neovascularization, Vascular endothelial growth factor A and Vascular endothelial growth factor. His studies deal with areas such as Inflammation and Cancer as well as Angiogenesis. Harold F. Dvorak studies Pathology, focusing on Vascular permeability in particular.
The study incorporates disciplines such as Blood vessel and Cancer therapy in addition to Neovascularization. His work in Vascular endothelial growth factor A is not limited to one particular discipline; it also encompasses Immunology. Harold F. Dvorak has researched Vascular endothelial growth factor in several fields, including Vasculogenesis and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing.
Harold F. Dvorak.
The New England Journal of Medicine (1986)
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
Donald R. Senger;Stephen J. Galli;Ann M. Dvorak;Carole A. Perruzzi.
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.
H. F. Dvorak;L. F. Brown;M. Detmar;A. M. Dvorak.
American Journal of Pathology (1995)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm;Anthony J. Tavares;Qin Dai;Seiichi Ohta;Seiichi Ohta.
Nature Reviews Materials (2016)
Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy
Harold F. Dvorak.
Journal of Clinical Oncology (2002)
Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
B Berse;L F Brown;L Van de Water;H F Dvorak.
Molecular Biology of the Cell (1992)
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1
Aernout Luttun;Marc Tjwa;Lieve Moons;Yan Wu.
Nature Medicine (2002)
Vascular permeability factor (VPF, VEGF) in tumor biology
D. R. Senger;L. Van De Water;L. F. Brown;J. A. Nagy.
Cancer and Metastasis Reviews (1993)
Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.
L. F. Brown;Kiang-Teck Yeo;B. Berse;Tet-Kin Yeo.
Journal of Experimental Medicine (1992)
Expression of Vascular Permeability Factor (Vascular Endothelial Growth Factor) and Its Receptors in Adenocarcinomas of the Gastrointestinal Tract
Lawrence F. Brown;Brygida Berse;Robert W. Jackman;Kathi Tognazzi.
Cancer Research (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: